Alpspure Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 06-10-2024
- Paid Up Capital ₹ 1.66 Cr
as on 06-10-2024
- Company Age 9 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 14.41 Cr
as on 06-10-2024
- Satisfied Charges ₹ 2.91 Cr
as on 06-10-2024
- Revenue 12.28%
(FY 2023)
- Profit 26.34%
(FY 2023)
- Ebitda 12.04%
(FY 2023)
- Net Worth 33.15%
(FY 2023)
- Total Assets 23.72%
(FY 2023)
About Alpspure Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.66 Cr.
The company currently has active open charges totaling ₹14.41 Cr. The company has closed loans amounting to ₹2.91 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sandeep Dahiya and Monika Dahiya serve as directors at the Company.
- CIN/LLPIN
U74140DL2015PTC284343
- Company No.
284343
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Aug 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Alpspure Lifesciences Private Limited offer?
Alpspure Lifesciences Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Zinc salts, Ayurvedic & Herbal Extracts, Plant Extracts, Herbal Extracts, Fruit Extracts, Nutraceuticals & Dietary Supplements, Nutraceuticals, Pharma Ingredients & Raw Materials, Vitamin Powder API.
Who are the key members and board of directors at Alpspure Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sandeep Dahiya  | Director | 20-Aug-2015 | Current |
| Monika Dahiya | Director | 20-Aug-2015 | Current |
Financial Performance of Alpspure Lifesciences.
Alpspure Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.28% increase. The company also saw a substantial improvement in profitability, with a 26.34% increase in profit. The company's net worth Soared by an impressive increase of 33.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alpspure Lifesciences?
In 2023, Alpspure Lifesciences had a public holding of 10.06%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alpspure Nutraceuticals Private LimitedActive 24 years 10 monthsSandeep Dahiya and Monika Dahiya are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 30 Nov 2021 | ₹4.65 M | Open |
Indian Bank Creation Date: 21 Jul 2020 | ₹7.00 M | Open |
Others Creation Date: 21 Nov 2019 | ₹13.25 Cr | Open |
How Many Employees Work at Alpspure Lifesciences?
Alpspure Lifesciences has a workforce of 28 employees as of Oct 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alpspure Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alpspure Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
